Your browser doesn't support javascript.
Viral Immunity and Vaccines in Hematologic Malignancies: Implications for COVID-19.
Dhodapkar, Madhav V; Dhodapkar, Kavita M; Ahmed, Rafi.
  • Dhodapkar MV; Department of Hematology/Medical Oncology, Emory University, Atlanta, Georgia.
  • Dhodapkar KM; Winship Cancer Institute, Emory University, Atlanta, Georgia.
  • Ahmed R; Winship Cancer Institute, Emory University, Atlanta, Georgia.
Blood Cancer Discov ; 2(1): 9-12, 2021 01.
Article in English | MEDLINE | ID: covidwho-1299253
ABSTRACT
Patients with hematologic malignancies have increased susceptibility to viral infections and suboptimal immunologic responses to current vaccines due to both disease-associated and therapy-related immune dysfunction. These considerations may impact the efficacy of emerging COVID-19 vaccines in this patient population as well and warrant the need to systematically study natural and vaccine-induced virus-specific immunity in these patients.
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Virus Diseases / Hematologic Neoplasms / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Blood Cancer Discov Year: 2021 Document Type: Article Affiliation country: 2643-3230.Bcd-20-0177

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Virus Diseases / Hematologic Neoplasms / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Blood Cancer Discov Year: 2021 Document Type: Article Affiliation country: 2643-3230.Bcd-20-0177